Global Macular Degeneration (AMD) and Other Retinal Diseases Industry Research Report 2020, Forecast to 2025

August 2020 | 103 pages | ID: G058D92443CAEN
WKinformation

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The Macular Degeneration (AMD) and Other Retinal Diseases market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Macular Degeneration (AMD) and Other Retinal Diseases is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.

The report offers detailed coverage of Macular Degeneration (AMD) and Other Retinal Diseases industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Macular Degeneration (AMD) and Other Retinal Diseases by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Macular Degeneration (AMD) and Other Retinal Diseases market are discussed.

The market is segmented by types:

• Wet AMD
• Dry AMD

It can be also divided by applications:

• Hospital
• Clinic
• Research Institute
• Other

And this report covers the historical situation, present status and the future prospects of the global Macular Degeneration (AMD) and Other Retinal Diseases market for 2015-2025. In this report, we analyze global market from 5 geographies: Asia-Pacific, Europe, North America, Middle East & Africa, South America.

Finally, the report provides detailed profile and data information analysis of leading company.

• Amgen Inc.
• Novartis AG
• Bausch Health Companies, Inc.
• F. Hoffmann-La Roche Ltd.
• Regeneron Pharmaceuticals Inc.

Report Includes:

• xx data tables and xx additional tables
• An overview of global Macular Degeneration (AMD) and Other Retinal Diseases market
• An detailed key players analysis across regions
• Analyses of global market trends, with historical data, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
• Insights into regulatory and environmental developments
• Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Macular Degeneration (AMD) and Other Retinal Diseases market
• Profiles of major players in the industry, including%li% Amgen Inc., Novartis AG, Bausch Health Companies, Inc., F. Hoffmann-La Roche Ltd., Regeneron Pharmaceuticals Inc......

Research Objectives

• To study and analyze the global Macular Degeneration (AMD) and Other Retinal Diseases consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.
• To understand the structure of Macular Degeneration (AMD) and Other Retinal Diseases market by identifying its various subsegments.
• Focuses on the key global Macular Degeneration (AMD) and Other Retinal Diseases manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
• To analyze the Macular Degeneration (AMD) and Other Retinal Diseases with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Macular Degeneration (AMD) and Other Retinal Diseases submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

Global Macular Degeneration (AMD) and Other Retinal Diseases Market Report 2020, Forecast to 2025

1 SCOPE OF THE STUDY

1.1 Macular Degeneration (AMD) and Other Retinal Diseases Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives

2 MACULAR DEGENERATION (AMD) AND OTHER RETINAL DISEASES INDUSTRY OVERVIEW

2.1 Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size (Million USD) Comparison by Regions (2020-2025)
  2.1.1 Macular Degeneration (AMD) and Other Retinal Diseases Global Import Market Analysis
  2.1.2 Macular Degeneration (AMD) and Other Retinal Diseases Global Export Market Analysis
  2.1.3 Macular Degeneration (AMD) and Other Retinal Diseases Global Main Region Market Analysis
2.2 Market Analysis by Type
  2.2.1 Wet AMD
  2.2.2 Dry AMD
2.3 Market Analysis by Application
  2.3.1 Hospital
  2.3.2 Clinic
  2.3.3 Research Institute
  2.3.4 Other
2.4 Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue, Sales and Market Share by Manufacturer
  2.4.1 Global Macular Degeneration (AMD) and Other Retinal Diseases Sales and Market Share by Manufacturer (2018-2020)
  2.4.2 Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue and Market Share by Manufacturer (2018-2020)
  2.4.3 Global Macular Degeneration (AMD) and Other Retinal Diseases Industry Concentration Ratio (CR5 and HHI)
  2.4.4 Top 5 Macular Degeneration (AMD) and Other Retinal Diseases Manufacturer Market Share
  2.4.5 Top 10 Macular Degeneration (AMD) and Other Retinal Diseases Manufacturer Market Share
  2.4.6 Date of Key Manufacturers Enter into Macular Degeneration (AMD) and Other Retinal Diseases Market
  2.4.7 Key Manufacturers Macular Degeneration (AMD) and Other Retinal Diseases Product Offered
  2.4.8 Mergers & Acquisitions Planning
2.5 Macular Degeneration (AMD) and Other Retinal Diseases Historical Development Overview
2.6 Market Dynamics
  2.6.1 Market Opportunities
  2.6.2 Market Risk
  2.6.3 Market Driving Force
  2.6.4 Porter's Five Forces Analysis
2.7 Coronavirus Disease 2019 (Covid-19): Macular Degeneration (AMD) and Other Retinal Diseases Industry Impact
  2.7.1 How the Covid-19 is Affecting the Macular Degeneration (AMD) and Other Retinal Diseases Industry
  2.7.2 Macular Degeneration (AMD) and Other Retinal Diseases Business Impact Assessment - Covid-19
  2.7.3 Market Trends and Macular Degeneration (AMD) and Other Retinal Diseases Potential Opportunities in the COVID-19 Landscape
  2.7.4 Measures / Proposal against Covid-19

3 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS

3.1 Upstream Analysis
  3.1.1 Macro Analysis of Upstream Markets
  3.1.2 Key Players in Upstream Markets
  3.1.3 Upstream Market Trend Analysis
  3.1.4 Macular Degeneration (AMD) and Other Retinal Diseases Manufacturing Cost Analysis
3.2 Downstream Market Analysis
  3.2.1 Macro Analysis of Down Markets
  3.2.2 Key Players in Down Markets
  3.2.3 Downstream Market Trend Analysis
  3.2.4 Sales Channel, Distributors, Traders and Dealers

4 GLOBAL MACULAR DEGENERATION (AMD) AND OTHER RETINAL DISEASES MARKET SIZE CATEGORIZED BY REGIONS (2015-2020)

4.1 Global Macular Degeneration (AMD) and Other Retinal Diseases Sales Market Share by Region
4.2 Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue Market Share by Region (2015-2019)
4.3 Global Macular Degeneration (AMD) and Other Retinal Diseases Sales, Revenue, Price and Gross Margin (2015-2020)
4.4 North America Macular Degeneration (AMD) and Other Retinal Diseases Market Size Detail
  4.4.1 North America Macular Degeneration (AMD) and Other Retinal Diseases Sales Growth Rate (2015-2020)
  4.4.2 North America Macular Degeneration (AMD) and Other Retinal Diseases Sales, Revenue, Price and Gross Margin (2015-2020)
4.5 Europe Macular Degeneration (AMD) and Other Retinal Diseases Market Size Detail
  4.5.1 Europe Macular Degeneration (AMD) and Other Retinal Diseases Sales Growth Rate (2015-2020)
  4.5.2 Europe Macular Degeneration (AMD) and Other Retinal Diseases Sales, Revenue, Price and Gross Margin (2015-2020)
4.6 Japan Macular Degeneration (AMD) and Other Retinal Diseases Market Size Detail
  4.6.1 Japan Macular Degeneration (AMD) and Other Retinal Diseases Sales Growth Rate (2015-2020)
  4.6.2 Japan Macular Degeneration (AMD) and Other Retinal Diseases Sales, Revenue, Price and Gross Margin (2015-2020)
4.7 China Macular Degeneration (AMD) and Other Retinal Diseases Market Size Detail
  4.7.1 China Macular Degeneration (AMD) and Other Retinal Diseases Sales Growth Rate (2015-2020)
  4.7.2 China Macular Degeneration (AMD) and Other Retinal Diseases Sales, Revenue, Price and Gross Margin (2015-2020)

5 GLOBAL MACULAR DEGENERATION (AMD) AND OTHER RETINAL DISEASES MARKET SEGMENT BY TYPE

5.1 Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue, Sales and Market Share by Type (2015-2020)
  5.1.1 Global Macular Degeneration (AMD) and Other Retinal Diseases Sales and Market Share by Type (2015-2020)
  5.1.2 Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue and Market Share by Type (2015-2020)
5.2 Wet AMD Sales Growth Rate and Price
  5.2.1 Global Wet AMD Sales Growth Rate (2015-2020)
  5.2.2 Global Wet AMD Price (2015-2020)
5.3 Dry AMD Sales Growth Rate and Price
  5.3.1 Global Dry AMD Sales Growth Rate (2015-2020)
  5.3.2 Global Dry AMD Price (2015-2020)

6 GLOBAL MACULAR DEGENERATION (AMD) AND OTHER RETINAL DISEASES MARKET SEGMENT BY APPLICATION

6.1 Global Macular Degeneration (AMD) and Other Retinal DiseasesSales Market Share by Application (2015-2020)
6.2 Hospital Sales Growth Rate (2015-2020)
6.3 Clinic Sales Growth Rate (2015-2020)
6.4 Research Institute Sales Growth Rate (2015-2020)
6.5 Other Sales Growth Rate (2015-2020)

7 GLOBAL MACULAR DEGENERATION (AMD) AND OTHER RETINAL DISEASES MARKET FORECAST

7.1 Global Macular Degeneration (AMD) and Other Retinal Diseases Sales, Revenue Forecast
  7.1.1 Global Macular Degeneration (AMD) and Other Retinal Diseases Sales Growth Rate Forecast (2020-2025)
  7.1.2 Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue and Growth Rate Forecast (2020-2025)
  7.1.3 Global Macular Degeneration (AMD) and Other Retinal Diseases Price and Trend Forecast (2020-2025)
7.2 Global Macular Degeneration (AMD) and Other Retinal Diseases Sales Forecast by Region (2020-2025)
  7.2.1 North America Macular Degeneration (AMD) and Other Retinal Diseases Sales, Revenue Forecast (2020-2025)
  7.2.2 Europe Macular Degeneration (AMD) and Other Retinal Diseases Sales, Revenue Forecast (2020-2025)
  7.2.3 Japan Macular Degeneration (AMD) and Other Retinal Diseases Production, Revenue Forecast (2020-2025)
  7.2.4 China Macular Degeneration (AMD) and Other Retinal Diseases Production, Revenue Forecast (2020-2025)

8 ANALYSIS OF MACULAR DEGENERATION (AMD) AND OTHER RETINAL DISEASES INDUSTRY KEY MANUFACTURERS

8.1 Amgen Inc.
  8.1.1 Company Details
  8.1.2 Product Information
  8.1.3 Amgen Inc. Macular Degeneration (AMD) and Other Retinal Diseases Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.1.4 Main Business Overview
  8.1.5 Amgen Inc. News
8.2 Novartis AG
  8.2.1 Company Details
  8.2.2 Product Information
  8.2.3 Novartis AG Macular Degeneration (AMD) and Other Retinal Diseases Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.2.4 Main Business Overview
  8.2.5 Novartis AG News
8.3 Bausch Health Companies, Inc.
  8.3.1 Company Details
  8.3.2 Product Information
  8.3.3 Bausch Health Companies, Inc. Macular Degeneration (AMD) and Other Retinal Diseases Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.3.4 Main Business Overview
  8.3.5 Bausch Health Companies, Inc. News
8.4 F. Hoffmann-La Roche Ltd.
  8.4.1 Company Details
  8.4.2 Product Information
  8.4.3 F. Hoffmann-La Roche Ltd. Macular Degeneration (AMD) and Other Retinal Diseases Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.4.4 Main Business Overview
  8.4.5 F. Hoffmann-La Roche Ltd. News
8.5 Regeneron Pharmaceuticals Inc.
  8.5.1 Company Details
  8.5.2 Product Information
  8.5.3 Regeneron Pharmaceuticals Inc. Macular Degeneration (AMD) and Other Retinal Diseases Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.5.4 Main Business Overview
  8.5.5 Regeneron Pharmaceuticals Inc. News

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Macular Degeneration (AMD) and Other Retinal Diseases Picture
Figure Research Programs/Design for This Report
Figure Global Macular Degeneration (AMD) and Other Retinal Diseases Market by Regions (2019)
Table Global Market Macular Degeneration (AMD) and Other Retinal Diseases Comparison by Regions (M USD) 2019-2025
Table Global Macular Degeneration (AMD) and Other Retinal Diseases Sales Growth (CAGR) (2019-2025) by Type
Figure Global Sales Market Share of Macular Degeneration (AMD) and Other Retinal Diseases by Type in 2019
Figure Wet AMD Picture
Figure Dry AMD Picture
Table Global Macular Degeneration (AMD) and Other Retinal Diseases Sales by Application (2019-2025)
Figure Global Macular Degeneration (AMD) and Other Retinal Diseases Sales Market Share by Application in 2019
Figure Hospital Picture
Figure Clinic Picture
Figure Research Institute Picture
Figure Other Picture
Table Global Macular Degeneration (AMD) and Other Retinal Diseases Sales by Manufacturer (2018-2020)
Figure Global Macular Degeneration (AMD) and Other Retinal Diseases Sales Market Share by Manufacturer in 2019
Table Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue by Manufacturer (2018-2020)
Figure Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue Market Share by Manufacturer in 2019
Table Global Macular Degeneration (AMD) and Other Retinal Diseases Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Macular Degeneration (AMD) and Other Retinal Diseases Manufacturer (Revenue) Market Share in 2019
Figure Top 10 Macular Degeneration (AMD) and Other Retinal Diseases Manufacturer (Revenue) Market Share in 2019
Table Date of Key Manufacturers Enter into Macular Degeneration (AMD) and Other Retinal Diseases Market
Table Key Manufacturers Macular Degeneration (AMD) and Other Retinal Diseases Product Type
Table Mergers & Acquisitions Planning
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Macular Degeneration (AMD) and Other Retinal Diseases
Table Key Players of Upstream Markets
Figure Sales Channel
Table Global Macular Degeneration (AMD) and Other Retinal Diseases Sales (K Units) by Region (2015-2020)
Table Global Macular Degeneration (AMD) and Other Retinal Diseases Sales Market Share by Region (2015-2019)
Figure Global Macular Degeneration (AMD) and Other Retinal Diseases Sales Market Share by Region (2015-2019)
Figure Global Macular Degeneration (AMD) and Other Retinal Diseases Sales Market Share by Region in 2018
Table Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue (Million US$) by Region (2015-2020)
Table Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue Market Share by Region (2015-2020)
Figure Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue Market Share by Region (2015-2020)
Figure Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue Market Share by Region in 2019
Table Global Macular Degeneration (AMD) and Other Retinal Diseases Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure North America Macular Degeneration (AMD) and Other Retinal Diseases Sales (K Units) Growth Rate (2015-2020)
Table North America Macular Degeneration (AMD) and Other Retinal Diseases Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Europe Macular Degeneration (AMD) and Other Retinal Diseases Sales (K Units) Growth Rate (2015-2020)
Table Europe Macular Degeneration (AMD) and Other Retinal Diseases Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Japan Macular Degeneration (AMD) and Other Retinal Diseases Sales (K Units) Growth Rate (2015-2020)
Table Japan Macular Degeneration (AMD) and Other Retinal Diseases Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure China Macular Degeneration (AMD) and Other Retinal Diseases Sales (K Units) Growth Rate (2015-2020)
Table China Macular Degeneration (AMD) and Other Retinal Diseases Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table Global Macular Degeneration (AMD) and Other Retinal Diseases Sales by Type (2015-2020)
Table Global Macular Degeneration (AMD) and Other Retinal Diseases Sales Market Share by Type (2015-2020)
Figure Global Macular Degeneration (AMD) and Other Retinal Diseases Sales Market Share by Type in 2019
Table Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue by Type (2015-2020)
Table Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue Market Share by Type (2015-2020)
Figure Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue Market Share by Type in 2019
Figure Global Wet AMD Sales Growth Rate (2015-2020)
Figure Global Wet AMD Price (2015-2020)
Figure Global Dry AMD Sales Growth Rate (2015-2020)
Figure Global Dry AMD Price (2015-2020)
Table Global Macular Degeneration (AMD) and Other Retinal Diseases Sales by Application (2015-2020)
Table Global Macular Degeneration (AMD) and Other Retinal Diseases Sales Market Share by Application (2015-2020)
Figure Global Macular Degeneration (AMD) and Other Retinal Diseases Sales Market Share by Application in 2019
Figure Global Hospital Sales Growth Rate (2015-2020)
Figure Global Clinic Sales Growth Rate (2015-2020)
Figure Global Research Institute Sales Growth Rate (2015-2020)
Figure Global Other Sales Growth Rate (2015-2020)
Figure Global Macular Degeneration (AMD) and Other Retinal Diseases Production (K Units) Growth Rate Forecast (2020-2025)
Figure Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Global Macular Degeneration (AMD) and Other Retinal Diseases Price and Trend Forecast (2020-2025)
Table Global Macular Degeneration (AMD) and Other Retinal Diseases Sales (K Units) Forecast by Region (2020-2025)
Figure Global Macular Degeneration (AMD) and Other Retinal Diseases Production Market Share Forecast by Region (2020-2025)
Figure North America Macular Degeneration (AMD) and Other Retinal Diseases Sales (K Units) Growth Rate Forecast (2020-2025)
Figure North America Macular Degeneration (AMD) and Other Retinal Diseases Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Europe Macular Degeneration (AMD) and Other Retinal Diseases Sales (K Units) Growth Rate Forecast (2020-2025)
Figure Europe Macular Degeneration (AMD) and Other Retinal Diseases Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Japan Macular Degeneration (AMD) and Other Retinal Diseases Production (K Units) Growth Rate Forecast (2020-2025)
Figure Japan Macular Degeneration (AMD) and Other Retinal Diseases Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure China Macular Degeneration (AMD) and Other Retinal Diseases Production (K Units) Growth Rate Forecast (2020-2025)
Figure China Macular Degeneration (AMD) and Other Retinal Diseases Revenue (Million US$) Growth Rate Forecast (2020-2025)
Table Amgen Inc. Company Profile
Figure Macular Degeneration (AMD) and Other Retinal Diseases Product Picture and Specifications of Amgen Inc.
Table Macular Degeneration (AMD) and Other Retinal Diseases Production, Price, Revenue and Gross Margin of 2018-2020
Figure Amgen Inc. Macular Degeneration (AMD) and Other Retinal Diseases Market Share (2018-2020)
Table Amgen Inc. Main Business
Table Amgen Inc. Recent Development
Table Novartis AG Company Profile
Figure Macular Degeneration (AMD) and Other Retinal Diseases Product Picture and Specifications of Novartis AG
Table Macular Degeneration (AMD) and Other Retinal Diseases Production, Price, Revenue and Gross Margin of 2018-2020
Figure Novartis AG Macular Degeneration (AMD) and Other Retinal Diseases Market Share (2018-2020)
Table Novartis AG Main Business
Table Novartis AG Recent Development
Table Bausch Health Companies, Inc. Company Profile
Figure Macular Degeneration (AMD) and Other Retinal Diseases Product Picture and Specifications of Bausch Health Companies, Inc.
Table Macular Degeneration (AMD) and Other Retinal Diseases Production, Price, Revenue and Gross Margin of 2018-2020
Figure Bausch Health Companies, Inc. Macular Degeneration (AMD) and Other Retinal Diseases Market Share (2018-2020)
Table Bausch Health Companies, Inc. Main Business
Table Bausch Health Companies, Inc. Recent Development
Table F. Hoffmann-La Roche Ltd. Company Profile
Figure Macular Degeneration (AMD) and Other Retinal Diseases Product Picture and Specifications of F. Hoffmann-La Roche Ltd.
Table Macular Degeneration (AMD) and Other Retinal Diseases Production, Price, Revenue and Gross Margin of 2018-2020
Figure F. Hoffmann-La Roche Ltd. Macular Degeneration (AMD) and Other Retinal Diseases Market Share (2018-2020)
Table F. Hoffmann-La Roche Ltd. Main Business
Table F. Hoffmann-La Roche Ltd. Recent Development
Table Regeneron Pharmaceuticals Inc. Company Profile
Figure Macular Degeneration (AMD) and Other Retinal Diseases Product Picture and Specifications of Regeneron Pharmaceuticals Inc.
Table Macular Degeneration (AMD) and Other Retinal Diseases Production, Price, Revenue and Gross Margin of 2018-2020
Figure Regeneron Pharmaceuticals Inc. Macular Degeneration (AMD) and Other Retinal Diseases Market Share (2018-2020)
Table Regeneron Pharmaceuticals Inc. Main Business
Table Regeneron Pharmaceuticals Inc. Recent Development
Table of Appendix